Growth Hormone Deficiency Marketplace Scrutinized in New GlobalData Report Recently Published at MarketPublishers.com
09 Nov 2015 • by Natalie Aster
LONDON – In 2014, total sales of growth hormone deficiency products across 7 major markets surpass the 1.25 billion mark. This marketplace is expected to post a CAGR of more than 4 percent in the years to come. It is set to be worth around USD 1.9 billion by 2025.
The USA is one of the major markets. The local market is set to grow at a swiftest pace in the years to come. In 2024, it is forecast to account for approximately 60 percent of global sales.
The launch of long-acting biobetter GH will be the main force spurring the growth.
Insightful research report “OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecast to 2024” drawn up by GlobalData provides an up-close look at the global GHD marketplace. The study contains a through overview of the disease and shares with a reader valuable details on the epidemiology. It offers information on the competitive environment and comprises product profiles. The report assesses unmet needs and examines opportunities. The research study includes a pipeline assessment and a pipeline valuation analysis.
OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecast to 2024
Published: August, 2015
Price: US$ 9,495.00
More new reports by this publisher can be found at GlobalData page.